journal article·2024-08Open access

The Compromised Fanconi Anemia Pathway in Prelamin A‐Expressing Cells Contributes to Replication Stress‐Induced Genomic Instability

Pengqing Nie, Cheng Zhang, Fengyi Wu, Shi Chen, Lianrong Wang

Advanced Science· Volume 11· Issue 30

Abstract

Abstract Genomic instability is not only a hallmark of senescent cells but also a key factor driving cellular senescence, and replication stress is the main source of genomic instability. Defective prelamin A processing caused by lamin A/C (LMNA) or zinc metallopeptidase STE24 (ZMPSTE24) gene mutations results in premature aging. Although previous studies have shown that dysregulated lamin A interferes with DNA replication and causes replication stress, the relationship between lamin A dysfunction and replication stress remains largely unknown. Here, an increase in baseline replication stress and genomic instability is found in prelamin A‐expressing cells. Moreover, prelamin A confers hypersensitivity of cells to exogenous replication stress, resulting in decreased cell survival and exacerbated genomic instability. These effects occur because prelamin A promotes MRE11‐mediated resection of stalled replication forks. Fanconi anemia (FA) proteins, which play important roles in replication fork maintenance, are downregulated by prelamin A in a retinoblastoma (RB)/E2F‐dependent manner. Additionally, prelamin A inhibits the activation of the FA pathway upon replication stress. More importantly, FA pathway downregulation is an upstream event of p53‐p21 axis activation during the induction of prelamin A expression. Overall, these findings highlight the critical role of FA pathway dysfunction in driving replication stress‐induced genomic instability and cellular senescence in prelamin A‐expressing cells.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: DNA Repair Mechanisms · Nuclear Structure and Function · Genomics and Chromatin Dynamics

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Gastroenterology Hubei Clinical Center and Key Laboratory of Intestinal and Colorectal Disease Ministry of Education Key Laboratory of Combinatorial Biosynthesis and Drug Discovery Taikang Center for Life and Medical Sciences Zhongnan Hospital of Wuhan University, School of Pharmaceutical Sciences, Wuhan University Wuhan 430071 China

Department of Infectious Diseases Institute of Pediatrics Shenzhen Children's Hospital Shenzhen Guangdong 518038 China

Department of Burn and Plastic Surgery Shenzhen Institute of Translational Medicine, Medical Innovation Technology Transformation Center of Shenzhen Second People's Hospital Shenzhen Key Laboratory of Microbiology in Genomic Modification & Editing and Application Guangdong Provincial Key Laboratory of Systems Biology and Synthetic Biology for Urogenital Tumors Shenzhen University Medical School, Shenzhen Second People's Hospital, The First Affiliated Hospital of Shenzhen University Shenzhen...

Funding

Fundamental Research Funds for the Central Universities

References (63)

Show source-provided references
1. 10.1016/j.ceb.2014.09.00910.1016/j.ceb.2014.09.009 ↗
2. 10.1146/annurev-genom-082908-15015010.1146/annurev-genom-082908-150150 ↗
3. 10.1126/science.108412510.1126/science.1084125 ↗
4. 10.1038/nature0162910.1038/nature01629 ↗
5. 10.1073/pnas.050600110210.1073/pnas.0506001102 ↗
6. 10.1038/ejhg.2013.25810.1038/ejhg.2013.258 ↗
7. 10.1016/j.ceb.2015.05.00710.1016/j.ceb.2015.05.007 ↗
8. 10.1016/j.molcel.2022.05.00410.1016/j.molcel.2022.05.004 ↗
9. 10.1080/19491034.2016.123968510.1080/19491034.2016.1239685 ↗
10. 10.1128/MCB.00659-1610.1128/MCB.00659-16 ↗
11. 10.1016/j.celrep.2018.01.09010.1016/j.celrep.2018.01.090 ↗
12. 10.1016/j.trecan.2017.10.00510.1016/j.trecan.2017.10.005 ↗
13. 10.1126/science.118237210.1126/science.1182372 ↗
14. 10.1016/j.trecan.2022.01.01510.1016/j.trecan.2022.01.015 ↗
15. 10.1016/j.molcel.2017.11.02210.1016/j.molcel.2017.11.022 ↗
16. 10.1093/nar/gkab34410.1093/nar/gkab344 ↗
17. 10.1038/nsmb.192710.1038/nsmb.1927 ↗
18. 10.1016/j.cell.2011.03.04110.1016/j.cell.2011.03.041 ↗
19. 10.1016/j.ccr.2012.05.01510.1016/j.ccr.2012.05.015 ↗
20. 10.1016/j.molcel.2018.05.01810.1016/j.molcel.2018.05.018 ↗
21. 10.1182/blood.201900378210.1182/blood.2019003782 ↗
22. 10.1038/s41556-022-00950-810.1038/s41556-022-00950-8 ↗
23. 10.1016/j.stem.2012.05.01310.1016/j.stem.2012.05.013 ↗
24. 10.1038/onc.2012.58310.1038/onc.2012.583 ↗
25. 10.1182/blood-2007-07-09921810.1182/blood-2007-07-099218 ↗
26. 10.1016/j.ebiom.2016.05.00510.1016/j.ebiom.2016.05.005 ↗
27. 10.1038/onc.2008.12110.1038/onc.2008.121 ↗
28. 10.1038/s41598-019-53502-w10.1038/s41598-019-53502-w ↗
29. 10.1016/j.mad.2004.07.01010.1016/j.mad.2004.07.010 ↗
30. 10.1161/CIRCULATIONAHA.109.90205610.1161/CIRCULATIONAHA.109.902056 ↗
31. 10.1242/jcs.13398310.1242/jcs.133983 ↗
32. 10.1073/pnas.070421210410.1073/pnas.0704212104 ↗
33. 10.1073/pnas.071216810510.1073/pnas.0712168105 ↗
34. 10.1083/jcb.20101108310.1083/jcb.201011083 ↗
35. 10.1038/ncb220110.1038/ncb2201 ↗
36. 10.1016/j.ceb.2021.01.00410.1016/j.ceb.2021.01.004 ↗
37. 10.1073/pnas.080784010510.1073/pnas.0807840105 ↗
38. 10.1073/pnas.120252910910.1073/pnas.1202529109 ↗
39. 10.1016/j.dnarep.2015.03.00710.1016/j.dnarep.2015.03.007 ↗
40. 10.1182/blood-2002-01-027810.1182/blood-2002-01-0278 ↗
41. 10.1074/jbc.M113.51133710.1074/jbc.M113.511337 ↗
42. 10.1016/j.jbc.2021.10130110.1016/j.jbc.2021.101301 ↗
43. 10.1128/MCB.01676-1210.1128/MCB.01676-12 ↗
44. 10.1038/s41594-018-0075-z10.1038/s41594-018-0075-z ↗
45. 10.1111/acel.1207010.1111/acel.12070 ↗
46. 10.1093/hmg/ddi15810.1093/hmg/ddi158 ↗
47. 10.4161/cc.2810510.4161/cc.28105 ↗
48. 10.1073/pnas.110278910810.1073/pnas.1102789108 ↗
49. 10.1038/ncomms1109110.1038/ncomms11091 ↗
50. 10.1038/s41418-022-00988-z10.1038/s41418-022-00988-z ↗
51. 10.1038/sj.onc.120904610.1038/sj.onc.1209046 ↗
52. 10.1172/JCI9514810.1172/JCI95148 ↗
53. 10.1038/nature0401910.1038/nature04019 ↗
54. 10.1038/cdd.2017.17210.1038/cdd.2017.172 ↗
55. 10.1016/j.molcel.2013.07.02310.1016/j.molcel.2013.07.023 ↗
56. 10.1074/jbc.M112.35799610.1074/jbc.M112.357996 ↗
57. 10.1083/jcb.20070815510.1083/jcb.200708155 ↗
58. 10.18632/oncotarget.179610.18632/oncotarget.1796 ↗
59. 10.1016/j.molcel.2015.09.01210.1016/j.molcel.2015.09.012 ↗
60. 10.1038/s41418-021-00764-510.1038/s41418-021-00764-5 ↗
61. 10.1016/j.arr.2016.06.00710.1016/j.arr.2016.06.007 ↗
62. 10.1038/s41580-020-00314-w10.1038/s41580-020-00314-w ↗
63. 10.1038/s41419-021-03484-310.1038/s41419-021-03484-3 ↗